INCATE: a partnership to boost the antibiotic pipeline

Comment

Authors: Alt, S., Haggstrom, D., Kessmann, H., Kloss, F., Schneider, C.E., Jäger, T., Schwede, T., Brakhage, A., and Dehio, C.

Published in: Nature Reviews Drug Discovery 2022

DOI: 10.1038/d41573-022-00138-7

Abstract:

INCATE, the INCubator for Antibacterial Therapies in Europe, aims to boost the antibiotic pipeline by accelerating the translation of academic innovation into industrial R&D projects to tackle antimicrobial resistance. Founded in 2021 as a partnership of research institutions and pharma companies, INCATE provides advice, community and non-dilutive funding to start-up companies.

Back to overview